| Day Low 01:21 PM EDT | 21.73 | |
|---|---|---|
| Day High 09:30 AM EDT | 22.06 |
|
| Range | 0.33 | |
| Volume | 14.13 M | |
| 30-Day Avg. Vol. | 13.41 M |
|
| Difference | 5.34% | |
| Market Cap. | 43.43 B | |
| Change | -59.38 M | |
| Shares Out. | 1.97 B | |
| Percent Traded | 0.71% | |
| Revenue | 19.34 B | |
| Earnings | 2.16 B | |
| EPS (TTM) | 1.07 |
| 52-Wk Low 3/17/08 | 20.05 | |
|---|---|---|
| 52-Wk High 7/18/07 | 32.35 |
|
| Range | 12.30 | |
| Prev. Close 5/15/08 | 21.97 | |
| Today's Open | 22.03 | |
| Change | 0.27% | |
| Dividend (TTM) | 1.18 | |
| Div. Yield (TTM) | 5.71% |
|
| Beta | 1.08 | |
| P/E Ratio (TTM) | 21.51 | |
| P/E Ratio (Fwd.) | — |
Pharmaceutical giant Bristol-Myers Squibb (BMS) makes big bucks on matters of the heart. The company's blockbuster cardiovascular line-up includes heart disease drug Plavix, as well as Pravachol (which ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| 2 Quarters Ago | 0.34 12/31/07 | 0.35 12/31/07 |
0.009
Beat
|
| Last Quarter | 0.41 3/31/08 | 0.42 3/31/08 |
0.009
Beat
|
| Quarterly - 03/31/2008 | Annual - 2007 | |
|---|---|---|
| Total Revenue | 5.18 B | 19.35 B |
| Gross Profit | 3.52 B | 13.31 B |
| Operating Income | 2.77 B | 3.88 B |
| Net Income | 661.00 M | 2.16 B |
